-
1دورية أكاديمية
المصدر: 2024 , ' Extended pleurectomy decortication and chemotherapy versus chemotherapy alone for pleural mesothelioma (MARS 2): a phase 3 randomised controlled trial : a phase 3 randomised controlled trial ' , Lancet Respiratory Medicine , vol. 12 , no. 6 , pp. 457-466 . https://doi.org/10.1016/S2213-2600Test(24)00119-X
مصطلحات موضوعية: Humans, Female, Male, Pleural Neoplasms/surgery, Middle Aged, Aged, Mesothelioma/surgery, Treatment Outcome, United Kingdom, Pleura/surgery, Mesothelioma, Malignant/surgery, Combined Modality Therapy/methods, Adult, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Lung Neoplasms/surgery
العلاقة: https://research-information.bris.ac.uk/en/publications/01acc053-93d4-491b-a128-d02ba0511ea3Test
الإتاحة: https://doi.org/10.1016/S2213-2600Test(24)00119-X
https://hdl.handle.net/1983/01acc053-93d4-491b-a128-d02ba0511ea3Test
https://research-information.bris.ac.uk/en/publications/01acc053-93d4-491b-a128-d02ba0511ea3Test -
2دورية أكاديمية
المؤلفون: Scheer, Monika, Vokuhl, Christian, Bauer, Sebastian, Fuchs, Jörg, Loff, Steffan, Timmermann, Beate, Münter, Marc, Henssen, Anton George, Kazanowska, Bernarda, Niggli, Felix, Ladenstein, Ruth, Ljungman, Gustaf, Koscielniak, Ewa, Klingebiel, Thomas
المصدر: http://lobid.org/resources/99370674181806441Test#!, 147(12):3735-3747.
مصطلحات موضوعية: Adolescent [MeSH], Female [MeSH], Sarcoma, Synovial/therapy [MeSH], Radiotherapy, Adjuvant/methods [MeSH], Combined Modality Therapy/methods [MeSH], Adult [MeSH], Original Article – Clinical Oncology, Humans [MeSH], Middle Aged [MeSH], Pediatric sarcoma, Infant [MeSH], Male [MeSH], Time [MeSH], Adjuvant therapies, Young Adult [MeSH], Chemotherapy, Soft-tissue sarcoma, Child [MeSH], Synovial sarcoma, Child, Preschool [MeSH]
العلاقة: https://repository.publisso.de/resource/frl:6449888Test; https://doi.org/10.1007/s00432-021-03614-6Test; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8557198Test/
الإتاحة: https://doi.org/10.1007/s00432-021-03614-6Test
https://repository.publisso.de/resource/frl:6449888Test
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8557198Test/ -
3دورية أكاديمية
المؤلفون: Ettrich, Thomas J., Seufferlein, Thomas
المصدر: http://lobid.org/resources/99370673470306441Test#!, 22(11):106.
مصطلحات موضوعية: Clinical Decision-Making [MeSH], Age Factors [MeSH], Neoplasm Grading [MeSH], Combined Modality Therapy/methods [MeSH], Molecular Diagnostic Techniques [MeSH], Metastatic, Disease Management [MeSH], Neoplasm Staging [MeSH], Pancreatic Neoplasms/therapy [MeSH], Topical Collection on Upper Gastrointestinal Cancers, Pancreatic Neoplasms/diagnosis [MeSH], Biomarkers, Tumor [MeSH], Pancreatic Neoplasms/mortality [MeSH], Pancreatic Neoplasms/etiology [MeSH], Pancreatic cancer, Retreatment [MeSH], Humans [MeSH], Neoplasm Metastasis [MeSH], Treatment Outcome [MeSH], Upper Gastrointestinal Cancers (JD Berlin, Section Editor), Disease Susceptibility [MeSH], Combined Modality Therapy/adverse effects [MeSH], Systemic therapy, Clinical Trials as Topic [MeSH], Prognosis [MeSH], Review, Chemotherapy
العلاقة: https://repository.publisso.de/resource/frl:6444380Test; https://doi.org/10.1007/s11864-021-00895-4Test; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8526424Test/
الإتاحة: https://doi.org/10.1007/s11864-021-00895-4Test
https://repository.publisso.de/resource/frl:6444380Test
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8526424Test/ -
4دورية أكاديمية
المؤلفون: Bernardo-Faura, Marti, Rinas, Melanie, Wirbel, Jakob, Pertsovskaya, Inna, Pliaka, Vicky, Messinis, Dimitris E., Vila, Gemma, Sakellaropoulos, Theodore, Faigle, Wolfgang, Stridh, Pernilla, Behrens, Janina R., Olsson, Tomas, Martin, Roland, Paul, Friedemann, Alexopoulos, Leonidas G., Villoslada, Pablo, Saez-Rodriguez, Julio
المصدر: http://lobid.org/resources/99370670445306441Test#!, 13(1):117.
مصطلحات موضوعية: Multiple Sclerosis/therapy [MeSH], Multiple Sclerosis/diagnosis [MeSH], Combined Modality Therapy/methods [MeSH], Phosphoproteomics, Phosphoproteins/metabolism [MeSH], Models, Biological [MeSH], Disease Management [MeSH], Personalized medicine, Immune System/immunology [MeSH], Male [MeSH], Signal Transduction/drug effects [MeSH], Case-Control Studies [MeSH], Network modeling, Treatment, Proteome [MeSH], Multiple Sclerosis/etiology [MeSH], Algorithms [MeSH], Female [MeSH], Proteomics/methods [MeSH], Adult [MeSH], Humans [MeSH], Multiple Sclerosis/metabolism [MeSH], Treatment Outcome [MeSH], Middle Aged [MeSH], Disease Susceptibility [MeSH], Immune System/drug effects [MeSH], Immune System/metabolism [MeSH], Molecular Targeted Therapy [MeSH], Pathways
العلاقة: https://repository.publisso.de/resource/frl:6465962Test; https://doi.org/10.1186/s13073-021-00925-8Test; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8284018Test/
الإتاحة: https://doi.org/10.1186/s13073-021-00925-8Test
https://repository.publisso.de/resource/frl:6465962Test
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8284018Test/ -
5دورية أكاديمية
المؤلفون: Dittner-Moormann, S., Reschke, M., Abbink, FCH, Aerts, I., Atalay, H.T., Fedorovna Bobrova, N., Biewald, E., Brecht, I.B., Caspi, S., Cassoux, N., Castela, G., Diarra, Y., Duncan, C., Ebinger, M., Garcia Aldana, D., Hadjistilianou, D., Kepák, T., Klett, A., Kiratli, H., Maka, E., Opocher, E., Pawinska-Wasikowska, K., Rascon, J., Russo, I., Rutynowska-Pronicka, O., Sábado Álvarez, C., Pacheco, SSR, Svojgr, K., Timmermann, B., Vishnevskia-Dai, V., Eggert, A., Ritter-Sovinz, P., Bechrakis, N.E., Jenkinson, H., Moll, A., Munier, F.L., Popovic, M.B., Chantada, G., Doz, F., Ketteler, P.
المصدر: Pediatric blood & cancer, vol. 68, no. 6, pp. e28963
مصطلحات موضوعية: Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Chemotherapy, Adjuvant/methods, Child, Preschool, Combined Modality Therapy/methods, Europe, Eye Enucleation, Humans, Prognosis, Radiotherapy, Retinal Neoplasms/pathology, Retinal Neoplasms/therapy, Retinoblastoma/pathology, Retinoblastoma/therapy, Risk Factors, Surveys and Questionnaires, RB1 gene, biomarker, childhood cancer, metastasis
وصف الملف: application/pdf
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/33720495; info:eu-repo/semantics/altIdentifier/eissn/1545-5017; info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_C745699D2ADF5; https://serval.unil.ch/notice/serval:BIB_C745699D2ADFTest; urn:issn:1545-5009; https://serval.unil.ch/resource/serval:BIB_C745699D2ADF.P001/REF.pdfTest; http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_C745699D2ADF5Test
الإتاحة: https://doi.org/10.1002/pbc.28963Test
https://serval.unil.ch/notice/serval:BIB_C745699D2ADFTest
https://serval.unil.ch/resource/serval:BIB_C745699D2ADF.P001/REF.pdfTest
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_C745699D2ADF5Test -
6دورية أكاديمية
المؤلفون: Thol, Felicitas, Ganser, Arnold
المصدر: http://lobid.org/resources/99370673470306441Test#!, 21(8):66.
مصطلحات موضوعية: Clinical Decision-Making [MeSH], Salavage chemotherapy, Combined Modality Therapy/methods [MeSH], Leukemia, Myeloid, Acute/etiology [MeSH], Retreatment [MeSH], Humans [MeSH], Treatment Outcome [MeSH], Acute/mortality [MeSH], Leukemia (PH Wiernik, Section Editor), Relapse AML, Disease Susceptibility [MeSH], Disease Management [MeSH], FLT3 inhibitors, Recurrence [MeSH], Combined Modality Therapy/adverse effects [MeSH], Standard of Care [MeSH], CPX-351, Venetoclax, Biomarkers, Tumor [MeSH], Acute/therapy [MeSH], Topical Collection on Leukemia, IDH1/IDH2 inhibitors, Acute/pathology [MeSH]
العلاقة: https://repository.publisso.de/resource/frl:6471250Test; https://doi.org/10.1007/s11864-020-00765-5Test; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7324428Test/
الإتاحة: https://doi.org/10.1007/s11864-020-00765-5Test
https://repository.publisso.de/resource/frl:6471250Test
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7324428Test/ -
7دورية أكاديمية
المؤلفون: Gruhn, Bernd, Brodt, Grit, Wittig, Susan, Ernst, Thomas, Ernst, Jana
المصدر: http://lobid.org/resources/99370678538206441Test#!, 99(5):1133-1134.
مصطلحات موضوعية: Combined Modality Therapy/methods [MeSH], Precursor Cell Lymphoblastic Leukemia-Lymphoma/diagnosis [MeSH], Humans [MeSH], Treatment Outcome [MeSH], Letter to the Editor, Bone Marrow Transplantation/methods [MeSH], Oncology, Antineoplastic Combined Chemotherapy Protocols/therapeutic use [MeSH], Hematology, Antineoplastic Combined Chemotherapy Protocols/adverse effects [MeSH], Infant [MeSH], Precursor Cell Lymphoblastic Leukemia-Lymphoma/genetics [MeSH], Biomarkers, Tumor/genetics [MeSH], Antineoplastic Agents, Immunological/administration, Remission Induction [MeSH], Precursor Cell Lymphoblastic Leukemia-Lymphoma/therapy [MeSH], Bone Marrow Transplantation/adverse effects [MeSH], Transplantation, Homologous [MeSH], High-Throughput Nucleotide Sequencing [MeSH]
العلاقة: https://repository.publisso.de/resource/frl:6466964Test; https://doi.org/10.1007/s00277-020-03957-zTest; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8277651Test/
الإتاحة: https://doi.org/10.1007/s00277-020-03957-zTest
https://repository.publisso.de/resource/frl:6466964Test
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8277651Test/ -
8دورية أكاديمية
المساهمون: Yun-Gyoo Lee, Eun Joo Kang, Bhumsuk Keam, Jin-Hyuk Choi, Jin-Soo Kim, Keon Uk Park, Kyoung Eun Lee, Jung Hye Kwon, Keun-Wook Lee, Min Kyoung Kim, Hee Kyung Ahn, Seong Hoon Shin, Hye Ryun Kim, Sung-Bae Kim, Hwan Jung Yun, Kim, Hye Ryun
مصطلحات موضوعية: Adult, Aged, 80 and over, Antimetabolites, Antineoplastic / therapeutic use, Antineoplastic Agents, Immunological / therapeutic use, Antineoplastic Combined Chemotherapy Protocols / therapeutic use, Cetuximab / therapeutic use, Chemoradiotherapy / methods, Cisplatin / therapeutic use, Combined Modality Therapy / methods, Docetaxel / therapeutic use, Female, Fluorouracil / therapeutic use, Follow-Up Studies, Head and Neck Neoplasms / drug therapy, Head and Neck Neoplasms / mortality, Head and Neck Neoplasms / surgery, Humans, Induction Chemotherapy / methods, Male, Middle Aged, Progression-Free Survival, Retrospective Studies, Squamous Cell Carcinoma of Head and Neck / drug therapy, Squamous Cell Carcinoma of Head and Neck / mortality, Squamous Cell Carcinoma of Head and Neck / surgery, Survival Rate, Young Adult
العلاقة: BMC CANCER; J00351; OAK-2021-02622; https://ir.ymlib.yonsei.ac.kr/handle/22282913/183920Test; T202007236; BMC CANCER, Vol.20(1) : 813, 2020-08
الإتاحة: https://doi.org/10.1186/s12885-020-07297-zTest
https://ir.ymlib.yonsei.ac.kr/handle/22282913/183920Test -
9دورية أكاديمية
المساهمون: Dedee F Murrell, Sandra Peña, Pascal Joly, Branka Marinovic, Takashi Hashimoto, Luis A Diaz, Animesh A Sinha, Aimee S Payne, Maryam Daneshpazhooh, Rüdiger Eming, Marcel F Jonkman, Daniel Mimouni, Luca Borradori, Soo-Chan Kim, Jun Yamagami, Julia S Lehman, Marwah Adly Saleh, Donna A Culton, Annette Czernik, John J Zone, David Fivenson, Hideyuki Ujiie, Katarzyna Wozniak, Ayşe Akman-Karakaş, Philippe Bernard, Neil J Korman, Frédéric Caux, Kossara Drenovska, Catherine Prost-Squarcioni, Snejina Vassileva, Ron J Feldman, Adela Rambi Cardones, Johann Bauer, Dimitrios Ioannides, Hana Jedlickova, Francis Palisson, Aikaterini Patsatsi, Soner Uzun, Savas Yayli, Detlef Zillikens, Masayuki Amagai, Michael Hertl, Enno Schmidt, Valeria Aoki, Sergei A Grando, Hiroshi Shimizu, Sharon Baum, Guiseppe Cianchini, Claudio Feliciani, Pilar Iranzo, Jose M Mascaró Jr, Cezary Kowalewski, Russell Hall, Richard Groves, Karen E Harman, M Peter Marinkovich, Emanual Maverakis, Victoria P Werth, Kim, Soo Chan
مصطلحات موضوعية: Academies and Institutes / standards, Administration, Intravenous, Antigens, CD20 / immunology, Combined Modality Therapy / methods, Combined Modality Therapy / standards, Consensus, Delphi Technique, Dermatology / methods, Dermatology / standards, Drug Therapy, Combination / methods, Combination / standards, Europe, Glucocorticoids / administration & dosage, Humans, Immunologic Factors / administration & dosage, Pemphigus / diagnosis, Pemphigus / immunology, Pemphigus / therapy, Plasmapheresis, Practice Guidelines as Topic, Rituximab / administration & dosage, Severity of Illness Index, CD20 inhibitor, guidelines, pemphigus foliaceus, pemphigus vulgaris, treatment
العلاقة: JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY; J01766; OAK-2022-03827; https://ir.ymlib.yonsei.ac.kr/handle/22282913/190177Test; T9992020402; JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, Vol.82(3) : 575-585.e1, 2020-03
الإتاحة: https://doi.org/10.1016/j.jaad.2018.02.021Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/190177Test -
10دورية أكاديمية
المساهمون: Hye-Kyung Jung, Chung Hyun Tae, Hye-Ah Lee, Hyuk Lee, Kee Don Choi, Jun Chul Park, Joong Goo Kwon, Yoon Jin Choi, Su Jin Hong, Jaekyu Sung, Woo Chul Chung, Ki Bae Kim, Seung Young Kim, Kyung Ho Song, Kyung Sik Park, Seong Woo Jeon, Byung-Wook Kim, Han Seung Ryu, Ok-Jae Lee, Gwang Ho Baik, Yong Sung Kim, Hwoon-Yong Jung, Park, Jun Chul
مصطلحات موضوعية: Aged, Chemoradiotherapy / methods, Combined Modality Therapy / methods, Esophageal Neoplasms / mortality, Esophageal Neoplasms / pathology, Esophageal Neoplasms / therapy, Esophageal Squamous Cell Carcinoma / mortality, Esophageal Squamous Cell Carcinoma / pathology, Esophageal Squamous Cell Carcinoma / therapy, Esophagectomy / methods, Esophagus / pathology, Female, Humans, Male, Middle Aged, Neoadjuvant Therapy / methods, Neoplasm Staging / methods, Prognosis, Republic of Korea, Retrospective Studies, Survival Rate
العلاقة: PLOS ONE; J02540; OAK-2022-03785; https://ir.ymlib.yonsei.ac.kr/handle/22282913/190144Test; T9992020369; PLOS ONE, Vol.15(4) : e0231456, 2020-04
الإتاحة: https://doi.org/10.1371/journal.pone.0231456Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/190144Test